Helicobacter pylori colonizes more than 50% of the world population thus, it is considered an important cause of gastric cancer.The aim of this study was to determine the isolation frequency of H. pylori in Southern Chile from patients with symptomatology compatible with gastritis or gastric ulcer and to correlate these findings with demographic parameters of infected patients and the susceptibility profiles of the isolated strains to the antimicrobial drugs used in the eradication treatments.A total of 240 patients were enrolled in the study. Each gastric biopsy was homogenized and seeded onto blood agar plates containing a selective antibiotics mixture (DENT supplement). Plates were incubated at 37° C in a microaerophilic environment for five days.The susceptibility profiles to amoxicillin, ciprofloxacin, clarithromycin, tetracycline and metronidazole were determined using the E-test method.H. pylori was isolated from 99 patients (41.3%) with slightly higher frequency in female (42% positive cultures) than male (40.2% positive cultures).With regard to age and educational level, the highest isolation frequencies were obtained in patients between 21–30 (55%) and 41–50 (52.6%) years old, and patients with secondary (43.9%) and university (46.2%) educational levels.Nineteen (21.6%) strains showed resistance to at least one antimicrobial drug. Tetracycline was the most active antimicrobial in vitro, whereas metronidazole was the less active. One strain (5.3%) showed resistance to amoxicillin, clarithomycin and metronidazole, simultaneously.
The susceptibility of 50 strains of Arcobacter butzleri isolated from chicken liver [12], mussels [18], river water [6] and bovine [5], duck [2] and pelicans [7] feces to mercury (Hg), chromium (Cr), silver (Ag), nickel (Ni), cobalt (Co), iron (Fe), manganese (Mn), molybdenum (Mo) and lead (Pb) was determined. All the strains were resistant to Mo, Mn, Ni, Co, Pb and Fe and susceptible to Hg, Ag and Cr. MIC values showed high variability, indicating a non homogeneous behavior among the strains.
Abstract. Modelling the risk of natural hazards for society, ecosystems, and the economy is subject to strong uncertainties, even more so in the context of a changing climate, evolving societies, growing economies, and declining ecosystems. Here, we present a new feature of the climate-risk modelling platform CLIMADA (CLIMate ADAptation), which allows us to carry out global uncertainty and sensitivity analysis. CLIMADA underpins the Economics of Climate Adaptation (ECA) methodology which provides decision-makers with a fact base to understand the impact of weather and climate on their economies, communities, and ecosystems, including the appraisal of bespoke adaptation options today and in future. We apply the new feature to an ECA analysis of risk from tropical cyclone storm surge to people in Vietnam to showcase the comprehensive treatment of uncertainty and sensitivity of the model outputs, such as the spatial distribution of risk exceedance probabilities or the benefits of different adaptation options. We argue that broader application of uncertainty and sensitivity analysis will enhance transparency and intercomparison of studies among climate-risk modellers and help focus future research. For decision-makers and other users of climate-risk modelling, uncertainty and sensitivity analysis has the potential to lead to better-informed decisions on climate adaptation. Beyond provision of uncertainty quantification, the presented approach does contextualize risk assessment and options appraisal, and might be used to inform the development of storylines and climate adaptation narratives.
Methicillin-resistant Staphylococcus aureus (MRSA) is a pathogen of public health importance. In Chile, the Cordobes/Chilean clone was the predominant healthcare-associated MRSA (HA-MRSA) clone in 1998. Since then, the molecular epidemiological surveillance of MRSA has not been performed in Southern Chile. We aimed to investigate the molecular epidemiology of HA-MRSA infections in Southern Chile to identify the MRSA clones involved, and their evolutionary relationships with epidemic international MRSA lineages. A total of 303 single inpatient isolates of S. aureus were collected in the Valdivia County Hospital (2007-2008), revealing 33% (100 MRSA/303) prevalence for HA-MRSA infections. The SCCmec types I and IV were identified in 97% and 3% of HA-MRSA, respectively. All isolates lacked the pvl genes. A random sample (n = 29) of all MRSA was studied by pulsed-field gel electrophoresis (PFGE), multilocus sequence typing (MLST), SCCmec subtyping, agr and spa typing, and virulence genes profiling. PFGE analysis revealed the predominance (89%, 26/29) of pulsotype A and three additional pulsotypes, designated H1, I33, and G1. Pulsotype A (ST5-SCCmecI-spa-t149) is clonally related to the Cordobes/Chilean clone. Pulsotype H1 (ST5-SCCmecIVNT-spa-t002) is genetically related to the Pediatric clone (ST5-SCCmecIV). Pulsotype I33 (ST5-SCCmecIVc-spa-t002) is clonally related by PFGE to the community-associated MRSA (CA-MRSA) clone spread in Argentina, I-ST5-IVa-PVL(+). The G1 pulsotype (ST8-SCCmecIVc-spa-t024) is clonally related to the epidemic USA300 CA-MRSA. Here, we demonstrate the stability of the Cordobes/Chilean clone over time as the major HA-MRSA clone in Southern Chile. The identification of two CA-MRSA clones might suggest that these clones have entered into the healthcare setting from the community. These results emphasize the importance of the local surveillance of MRSA infections in the community and hospital settings.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.